EQUASENS (EQS.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:EQS - FR0012882389 - Common Stock
41.725 EUR
+0.33 (+0.79%)
We assign a fundamental rating of 6 out of 10 to EQS. EQS was compared to 11 industry peers in the Health Care Technology industry. While EQS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. EQS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year EQS was profitable.
In the past year EQS had a positive cash flow from operations.
EQS had positive earnings in each of the past 5 years.
EQS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 8.84%, EQS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
EQS has a Return On Equity of 15.79%. This is amongst the best in the industry. EQS outperforms 90.91% of its industry peers.
EQS has a Return On Invested Capital of 12.70%. This is amongst the best in the industry. EQS outperforms 90.91% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EQS is significantly above the industry average of 9.17%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROIC | 12.7% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
EQS has a Profit Margin of 16.15%. This is amongst the best in the industry. EQS outperforms 81.82% of its industry peers.
In the last couple of years the Profit Margin of EQS has remained more or less at the same level.
EQS has a Operating Margin of 19.80%. This is amongst the best in the industry. EQS outperforms 81.82% of its industry peers.
In the last couple of years the Operating Margin of EQS has declined.
Looking at the Gross Margin, with a value of 68.81%, EQS is doing worse than 72.73% of the companies in the same industry.
EQS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EQS is creating value.
EQS has about the same amout of shares outstanding than it did 1 year ago.
EQS has more shares outstanding than it did 5 years ago.
EQS has a better debt/assets ratio than last year.
2.2 Solvency
EQS has an Altman-Z score of 3.90. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
EQS has a better Altman-Z score (3.90) than 63.64% of its industry peers.
The Debt to FCF ratio of EQS is 0.98, which is an excellent value as it means it would take EQS, only 0.98 years of fcf income to pay off all of its debts.
EQS has a Debt to FCF ratio of 0.98. This is in the better half of the industry: EQS outperforms 63.64% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that EQS is not too dependend on debt financing.
EQS has a Debt to Equity ratio (0.09) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Altman-Z | 3.9 |
ROIC/WACC1.64
WACC7.75%
2.3 Liquidity
A Current Ratio of 1.29 indicates that EQS should not have too much problems paying its short term obligations.
The Current ratio of EQS (1.29) is worse than 63.64% of its industry peers.
A Quick Ratio of 1.20 indicates that EQS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.20, EQS is doing worse than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
The earnings per share for EQS have decreased strongly by -14.07% in the last year.
The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
EQS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.45%.
The Revenue has been growing slightly by 6.45% on average over the past years.
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
3.2 Future
The Earnings Per Share is expected to grow by 18.63% on average over the next years. This is quite good.
Based on estimates for the next years, EQS will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y13%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 17.46, EQS is valued on the expensive side.
Based on the Price/Earnings ratio, EQS is valued a bit cheaper than 72.73% of the companies in the same industry.
When comparing the Price/Earnings ratio of EQS to the average of the S&P500 Index (26.37), we can say EQS is valued slightly cheaper.
EQS is valuated correctly with a Price/Forward Earnings ratio of 13.18.
81.82% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of EQS to the average of the S&P500 Index (36.20), we can say EQS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.46 | ||
| Fwd PE | 13.18 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EQS indicates a rather cheap valuation: EQS is cheaper than 81.82% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EQS indicates a somewhat cheap valuation: EQS is cheaper than 72.73% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.04 | ||
| EV/EBITDA | 8.54 |
4.3 Compensation for Growth
EQS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
EQS has a very decent profitability rating, which may justify a higher PE ratio.
EQS's earnings are expected to grow with 18.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.34
PEG (5Y)3.41
EPS Next 2Y17.52%
EPS Next 3Y18.63%
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 2.91%.
Compared to an average industry Dividend Yield of 3.46, EQS pays a bit more dividend than its industry peers.
EQS's Dividend Yield is a higher than the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
5.2 History
The dividend of EQS is nicely growing with an annual growth rate of 8.00%!
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
EQS pays out 51.75% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.75%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPA:EQS (12/4/2025, 9:42:07 AM)
41.725
+0.33 (+0.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.62%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap632.97M
Revenue(TTM)224.73M
Net Income(TTM)36.30M
Analysts83.33
Price Target52.36 (25.49%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.75%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.7%
PT rev (3m)3.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.82%
EPS NY rev (3m)-4.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.46 | ||
| Fwd PE | 13.18 | ||
| P/S | 2.82 | ||
| P/FCF | 17.04 | ||
| P/OCF | 13.12 | ||
| P/B | 2.75 | ||
| P/tB | 7.92 | ||
| EV/EBITDA | 8.54 |
EPS(TTM)2.39
EY5.73%
EPS(NY)3.17
Fwd EY7.59%
FCF(TTM)2.45
FCFY5.87%
OCF(TTM)3.18
OCFY7.62%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.34
PEG (5Y)3.41
Graham Number28.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROCE | 15.59% | ||
| ROIC | 12.7% | ||
| ROICexc | 17.92% | ||
| ROICexgc | 69.44% | ||
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% | ||
| FCFM | 16.53% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-25.09%
ROICexgc growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 69.34% | ||
| Cap/Sales | 4.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.71% | ||
| Profit Quality | 102.29% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 3.9 |
F-Score7
WACC7.75%
ROIC/WACC1.64
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y13%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-8.02%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year59.12%
EBIT Next 3Y27.46%
EBIT Next 5YN/A
FCF growth 1Y-36.73%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-31.7%
OCF growth 3Y0.02%
OCF growth 5Y3.18%
EQUASENS / EQS.PA FAQ
What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.
What is the valuation status for EQS stock?
ChartMill assigns a valuation rating of 6 / 10 to EQUASENS (EQS.PA). This can be considered as Fairly Valued.
What is the profitability of EQS stock?
EQUASENS (EQS.PA) has a profitability rating of 7 / 10.
What is the expected EPS growth for EQUASENS (EQS.PA) stock?
The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 13% in the next year.
Can you provide the dividend sustainability for EQS stock?
The dividend rating of EQUASENS (EQS.PA) is 6 / 10 and the dividend payout ratio is 51.75%.